Literature DB >> 9546359

Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain.

H Funato1, M Yoshimura, T Yamazaki, T C Saido, Y Ito, J Yokofujita, R Okeda, Y Ihara.   

Abstract

Amyloid beta-protein (Abeta) is the major component of senile plaques that emerge in the cortex during aging and appear most abundantly in Alzheimer's disease. In the course of our immunocytochemical study on a large number of autopsy cases, we noticed, in many aged nondemented cases, the presence of unique diffuse plaques in the cortex distinct from ordinary diffuse plaques by immunocytochemistry. The former were amorphous, very faintly Abeta-immunoreactive plaques resembling diffuse plaques, but they stained for Abeta40 and were associated with small cells containing Abeta-positive granules. A panel of amino- and carboxyl-terminal-specific Abeta antibodies showed that such Abeta40-positive diffuse plaques and cell-associated granules were composed exclusively of amino-terminally deleted Abeta terminating at Abeta40, -42, and -43. Double immunostaining also showed that those Abeta-immunoreactive granules are located in astrocytes and not in microglia or neurons. Immunoelectron microscopy revealed that nonfibrillar Abeta immunoreactivity was located within lipofuscin-like granules in somewhat swollen astrocytes. These findings raise the possibility that astrocytes take up Abeta and attempt to degrade it in lysosomes in the aged brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546359      PMCID: PMC1858251     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections.

Authors:  G Cattoretti; S Pileri; C Parravicini; M H Becker; S Poggi; C Bifulco; G Key; L D'Amato; E Sabattini; E Feudale
Journal:  J Pathol       Date:  1993-10       Impact factor: 7.996

2.  Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro.

Authors:  C J Pike; M J Overman; C W Cotman
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

3.  Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils.

Authors:  J El Khoury; S E Hickman; C A Thomas; L Cao; S C Silverstein; J D Loike
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

4.  Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein.

Authors:  H Akiyama; C Schwab; H Kondo; H Mori; F Kametani; K Ikeda; P L McGeer
Journal:  Neurosci Lett       Date:  1996-03-15       Impact factor: 3.046

5.  Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex.

Authors:  W Q Qiu; W Borth; Z Ye; C Haass; D B Teplow; D J Selkoe
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

6.  RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

Authors:  S D Yan; X Chen; J Fu; M Chen; H Zhu; A Roher; T Slattery; L Zhao; M Nagashima; J Morser; A Migheli; P Nawroth; D Stern; A M Schmidt
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

7.  The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide.

Authors:  K Boland; M Behrens; D Choi; K Manias; D H Perlmutter
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

8.  Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.

Authors:  G Evin; R Cappai; Q X Li; J G Culvenor; D H Small; K Beyreuther; C L Masters
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

9.  Amyloid beta protein (A beta) removal by neuroglial cells in culture.

Authors:  L M Shaffer; M D Dority; R Gupta-Bansal; R C Frederickson; S G Younkin; K R Brunden
Journal:  Neurobiol Aging       Date:  1995 Sep-Oct       Impact factor: 4.673

10.  GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.

Authors:  K Yanagisawa; A Odaka; N Suzuki; Y Ihara
Journal:  Nat Med       Date:  1995-10       Impact factor: 53.440

View more
  47 in total

Review 1.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

Review 2.  The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders.

Authors:  W K Jo; A C K Law; S K Chung
Journal:  Mol Psychiatry       Date:  2014-01-07       Impact factor: 15.992

Review 3.  Protein astrogliopathies in human neurodegenerative diseases and aging.

Authors:  Gabor G Kovacs; Virginia M Lee; John Q Trojanowski
Journal:  Brain Pathol       Date:  2017-09       Impact factor: 6.508

Review 4.  Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.

Authors:  Tien-Phat V Huynh; Albert A Davis; Jason D Ulrich; David M Holtzman
Journal:  J Lipid Res       Date:  2017-02-27       Impact factor: 5.922

5.  Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes.

Authors:  Jacob M Basak; Philip B Verghese; Hyejin Yoon; Jungsu Kim; David M Holtzman
Journal:  J Biol Chem       Date:  2012-03-01       Impact factor: 5.157

6.  Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Authors:  K T Shaw; T Utsuki; J Rogers; Q S Yu; K Sambamurti; A Brossi; Y W Ge; D K Lahiri; N H Greig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

7.  Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.

Authors:  Bernardetta Maresca; Maria Stefania Spagnuolo; Luisa Cigliano
Journal:  J Mol Neurosci       Date:  2014-11-18       Impact factor: 3.444

8.  Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.

Authors:  Monica Javidnia; Michaeline L Hebron; Yue Xin; Nikolas G Kinney; Charbel E-H Moussa
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

10.  Low levels of amyloid-beta and its transporters in neonatal rats with and without hydrocephalus.

Authors:  Kelley E Deren; Jennifer Forsyth; Osama Abdullah; Edward W Hsu; Petra M Klinge; Gerald D Silverberg; Conrad E Johanson; James P McAllister
Journal:  Cerebrospinal Fluid Res       Date:  2009-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.